100Unicorns
Be the 'Y Combinator of India' — provide initial capital plus committed follow-on to idea-stage startups, supporting them across their first three funding rounds before connecting them to large VCs for growth capital.
Capital for digital health, medtech-adjacent software, care delivery, and wellness platforms.
Healthtech and wellness investors back companies improving access, outcomes, or efficiency across care, diagnostics, pharma supply, and consumer wellness. India offers huge demand and messy delivery — which means distribution partnerships, trust, and regulation matter as much as product.
Expect questions on clinical credibility, provider or patient acquisition, reimbursement or payment mix, and whether growth depends on continuous subsidy. B2B health software and infrastructure often underwrite more cleanly than pure consumer wellness with weak retention.
Pitch the care or ops problem narrowly, show proof someone will pay repeatedly, and be honest about what requires licenses, clinical validation, or hospital sales cycles.
Be the 'Y Combinator of India' — provide initial capital plus committed follow-on to idea-stage startups, supporting them across their first three funding rounds before connecting them to large VCs for growth capital.
77 Capital backs early-stage Indian startups at Pre-Seed and Seed stages, focusing on SaaS, B2B marketplaces, FinTech, and HealthTech through a syndicate model that brings together aligned capital and operator networks.
DeepTech-focused VC backing startups with strong scientific and research foundations that can fundamentally transform industries and economies; invests and enables, leveraging Middle East and Europe relationships to help portfolio companies expand globally and raise larger follow-on rounds.
Back India's next generation of growth-stage companies across sectors
Build an expansive, India-centric platform of investment opportunities — make direct investments in technology-driven businesses with large India-first market potential, while seeding and anchoring entrepreneurial fund managers as a prime LP to broaden access to the startup ecosystem and keep companies domiciled in India.
Pioneer impact investing in India's most underserved communities
Abhinav Lal focuses on Pre-Seed, Seed opportunities across Health, operating as a Angel / Individual relevant to Indian founders.
Back bold founders from idea to IPO; Fund VIII centres on AI (enterprise, services-as-software, vertical AI) and consumer (Bharat, India-native, aspirational brands).
ah! Ventures democratizes startup investing in India by connecting early-stage founders with a curated, pan-India network of angel investors, backing ventures from Pre-Seed through Pre-Series A across sectors including SaaS, Consumer, FinTech, and HealthTech.
India-focused healthcare and wellness fund investing exclusively in scalable companies with validated product-market fit, governance-aligned leadership and a clear pathway to institutional scale; sector specialisation plus long-term partnership capital.
Ankit Nagori focuses on Pre-Seed, Seed opportunities across Consumer / D2C, Health, operating as a Angel / Individual relevant to Indian founders.
Invest in businesses solving fundamental needs in India - food, health, energy and education
Anthill Ventures backs early-stage Indian startups at Pre-Seed to Pre-Series A, focusing on founders building scalable businesses in Web3, Health Tech, Consumer Internet, CleanTech, and PropTech with strong product-market fit potential.
Back scalable, innovative solutions to real-life problems across tech and consumer/D2C; an operator-investor who mentors founders on building and scaling, with a sharp eye on unit economics.
Apollo Connect / Apollo Hospitals Ventures focuses on Seed, Series A opportunities across Health, operating as a Corporate / CVC relevant to Indian founders.
Back tech founders solving problems for the next 500 million Indians
Ascent Capital backs growth-stage Indian companies at Series B and beyond, focusing on businesses with proven models in Consumer, FinTech, Healthcare, Education, and Technology that are ready to scale meaningfully across Indian markets.
Ashvik Kapital backs early-stage Indian startups across D2C, FinTech, Logistics, and Health Tech, deploying syndicated capital from Pre-Seed through Series A to founders building scalable, consumer-facing or technology-driven businesses.
Athera Venture Partners backs early-stage technology-driven companies in India, partnering with founders at Seed through Series A to help build category-defining businesses with strong unit economics and scalable models.
Partner with global teams on a mission to solve the world's most important problems; founder-first, impact-oriented investing with gender-lens principles, prioritising defensible IP and scalable models.
Axilor Ventures backs early-stage Indian startups across SaaS, Consumer, FinTech, HealthTech, and B2B through structured accelerator programs and direct capital, targeting pre-seed to pre-Series A founders ready to validate and scale.
B Capital backs technology companies enabling digital transformation across enterprise, fintech, healthtech, and SaaS, with a focus on growth-stage businesses demonstrating clear scalability across emerging and developed markets.
Bangalore Bioinnovation Centre Angels / BBC focuses on Pre-Seed, Seed opportunities across Health, Deep Tech, operating as a Accelerator relevant to Indian founders.
Beyond Capital Ventures backs early-stage companies in India and emerging markets that improve outcomes for underserved communities, with a deliberate gender lens applied across HealthTech, FinTech, AgriTech, Education, and Consumer sectors.
Continue exploring
Pair this thesis with the right stage, then shortlist matching funds.
Operator angels, founder syndicates, and funds that invest like builders who have been in the seat.
Capital that underwrites India as the primary market — including Tier 2/3, vernacular, and mass adoption stories.
Investors who back software, platforms, and product-led companies where technology is the core moat.
Investors who write the first institutional cheque and partner before the story is obvious.